Keyphrases
Major Depressive Disorder
91%
Non-suicidal Self-injury
63%
Resting-state Functional Connectivity (rs-FC)
37%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
32%
Amygdala
23%
Obsessive-compulsive Disorder
22%
Suicidal Ideation
21%
Older Adults
21%
Depressive Symptoms
21%
Healthy Controls
19%
Functional Magnetic Resonance Imaging
19%
Adolescent Major Depressive Disorder
18%
Borderline Personality Disorder
18%
Treatment-resistant Depression
18%
Neural Correlates
17%
Depressed Adolescents
16%
Neurobiology
16%
Resting State
16%
Mood Disorders
15%
White Matter Microstructure
15%
Cortical Thickness
15%
Adolescents with Depression
15%
Early Intervention
14%
Ketamine
14%
Psychiatric Disorders
13%
Schizophrenia
13%
Psychopathology
13%
Adolescent Depression
12%
Fronto-limbic
12%
Treatment Response
12%
Brain Regions
12%
Bipolar Disorder
12%
Dorsal Anterior Cingulate Cortex (dACC)
12%
HPA Axis
11%
Clinical Improvement
11%
Fractional Anisotropy
11%
Functional Connectivity
10%
Suicide
9%
Suicidality
9%
United States
9%
Neuroscience Research
9%
Mega-analysis
9%
Posttraumatic Stress Disorder
9%
Stress System
9%
N-acetylcysteine
9%
Interpersonal Psychotherapy
9%
Insula
8%
Diffusion Tensor Imaging
8%
Emotional Faces
8%
Anatomical Connectivity
8%
Neuroscience
Major Depressive Disorder
100%
Resting-State Functional Connectivity
39%
Functional Magnetic Resonance Imaging
38%
Amygdala
33%
Automutilation
29%
Functional Connectivity
21%
Antidepressant
19%
Borderline Personality Disorder
18%
Behavior (Neuroscience)
18%
Adolescent Depression
15%
Mood Disorder
15%
Ketamine
15%
Anterior Cingulate Cortex
15%
Treatment-Resistant Depression
15%
Bipolar Disorder
14%
Fractional Anisotropy
12%
Neurobiology
11%
Obsessive-Compulsive Disorder
11%
Cortisol
11%
Face
10%
Depression
10%
Diffusion MRI
9%
Brain Network
9%
Posttraumatic Stress Disorder
9%
Diffusion Tensor Imaging
8%
Hippocampus
8%
Brain Development
7%
Gene Expression
7%
Hypothalamic-Pituitary-Adrenal Axis
7%
Orbitofrontal Cortex
7%
Precuneus
7%
Meta-Analysis
7%
Selective Serotonin Reuptake Inhibitor
6%
Acetylcysteine
6%
Inflammasome
6%
Limbic System
6%
Transcranial Magnetic Stimulation
6%
Attention Deficit Hyperactivity Disorder
5%
Placebo
5%
Frontal Lobe
5%
Pediatric Obsessive Compulsive Disorder
5%
Putamen
5%